外泌体研究市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、适应症、按应用、地区和竞争细分

2022 年外泌体研究市场价值为1.8907 亿美元，预计到2028 年将以13.71% 的复合年增长率实现显着增长。这种增长可归因于研发资金的激增，以及日益流行的外泌体研究市场。癌症和对基于外泌体的手术的兴趣日益浓厚。此外，用于药物开发和发现的外泌体技术的不断进步预计将在这一预测时间内产生利润丰厚的成长。同样，药物治疗需求的不断增长以及製药业研发活动的激增仍然是多年来推动市场扩张的关键因素。值得注意的是，GLOBOCAN 2020 报告强调，全球癌症人口为 1,929 万，预计这一数字在未来二十年将在全球范围内激增。癌症病例的不断增加表明外泌体在癌症管理中发挥重要作用的潜力很大，进一步促进了预期的市场成长。

扩大研究经费作为外泌体市场扩张的催化剂

研究经费的大幅增加是全球外泌体研究市场显着成长的关键驱动力。这种不断增加的资金使研究人员能够对外泌体进行更广泛和更全面的研究，最终导致对其生物学和前瞻性临床应用有更深刻的了解。研究经费的增加促进了外泌体分离、分析和表征的新技术和方法的发展。这反过来又导致了外泌体研究市场中新产品、服务、诊断和治疗应用的创建。随着资金的增加，研究人员可以拓宽外泌体研究的视野，使他们能够探索外泌体生物学的新方面，并研究它们在更广泛的疾病和病症中的潜在作用。研究范围的扩大极大地增强了我们对外泌体临床应用的理解，从而推动了外泌体研究市场的成长。

市场概况
预测期	2024-2028
2022 年市场规模	18907万美元
2028 年市场规模	40419万美元
2023-2028 年复合年增长率	13.71%
成长最快的细分市场	癌症
最大的市场	北美洲

研究经费的增加将外泌体研究转变为更具吸引力的投资领域，导致外泌体研究市场上出现了新的公司和产品。这种投资的激增刺激了创新并加速了基于外泌体的疗法和诊断的开发。值得注意的是，几家公司已扩大其产品组合以涵盖基于外泌体的疗法。例如，Codiak Biosciences 与 Jazz Pharmaceuticals 合作，开创了以外泌体为基础的癌症治疗疗法。外泌体研究市场的关键焦点是开发改良的外泌体分离技术。该领域的最新进展包括利用微流体装置进行高通量外泌体分离，以及发展从特定细胞类型分离外泌体的新技术。

外泌体分离与分析技术的进步

外泌体分离和分析相关技术的进步对全球外泌体研究市场产生了深远的影响。这些突破简化并增强了外泌体的研究过程，有助于更全面地了解其生物学和潜在的临床应用。这些技术进步提高了准确性和效率，使研究人员能够获得高品质的外泌体样本并以更快的速度和精度进行分析。研究和开发活动的加速因此推动了外泌体研究市场的成长。新技术的出现使得即使是微量的外泌体也能被检测和分析，提高了基于外泌体的检测的灵敏度，并最终获得更准确的结果。这揭示了新的研究途径，并催化了外泌体研究市场中新颖产品和服务的推出。

对外泌体临床潜力的认识增强刺激了市场前景

人们对外泌体潜在临床应用的日益认识对全球外泌体研究市场产生了显着影响。随着研究人员和医疗专业人员越来越熟悉外泌体的独特属性和功能，人们对其作为治疗和诊断工具的潜力的兴趣呈指数级增长。随着人们对外泌体潜在临床应用的认识不断提高，对基于外泌体的治疗和诊断开发的投资也随之激增。这最终导致外泌体研究市场中新公司和新产品的形成，从而推动成长并促进创新。外泌体的潜在临床应用涵盖多种疾病和病症，包括癌症、神经系统疾病和心血管疾病。

人们对这种潜力的认识不断提高，促使人们加强开发基于外泌体的疗法，从而引发外泌体研究市场中创新产品和服务的创建。此外，外泌体已被证明有望作为诊断各种疾病和病症的生物标记。人们对这种潜力的认识不断增强，随后催化了新的基于外泌体的诊断测试的製定，从而推动了外泌体研究市场的成长。随着基于外泌体的疗法和诊断越来越接近临床实施，监管机构越来越深入参与开发和审批流程。人们对外泌体潜在临床应用的认识不断增强，促使监管部门加强审查，从而增强了基于外泌体的产品和服务的安全性和有效性。

慢性病盛行率激增为外泌体研究市场注入活力

慢性病的盛行率不断上升对全球外泌体研究市场产生了重大影响。值得注意的是，癌症、心血管疾病和神经系统疾病等慢性疾病带来了巨大的公共卫生挑战，影响着全球数百万人。外泌体已成为解决这些和其他慢性病的潜在诊断和治疗工具，从而促进了外泌体研究市场的成长。

慢性病的激增促使研究重点加强，为探索外泌体在疾病诊断、治疗和监测中的潜在作用提供了一个平台。随着研究人员深入研究外泌体作为生物标记和治疗剂的潜力，该市场持续蓬勃发展。外泌体引入了一种新的治疗方法，能够将药物和遗传物质输送到特定的细胞和组织。

为了应对日益流行的慢性病，​​对创新疗法的需求不断增长，推动了基于外泌体的疗法和产品的开发。值得注意的是，人们正在研究外泌体作为多种慢性疾病诊断工具的潜力。透过分析体液中存在的外泌体，研究人员可以识别出显示疾病存在的生物标记。这反过来又刺激了基于外泌体的新诊断工具的开发，最终有助于外泌体研究市场的扩张。随着外泌体成为应对日益严重的慢性疾病带来的挑战的有前途的解决方案，外泌体研究市场响应了这一需求，实现了成长和相关性。

市场区隔

全球外泌体研究市场可以按产品、适应症、应用和地区进行细分。根据产品，市场可分为试剂盒和试剂、仪器和其他产品。根据适应症，市场可分为癌症、神经退化性疾病、心血管疾病、传染病等。根据应用，市场可分为生物标记、疫苗开发、组织再生和其他应用。

市场参与者

Thermo Fisher Scientific.、System Biosciences.、Bio-Techne.、Lonza.、QIAGEN.、ExoDx.、Hitachi Chemical.、Aethlon Medical.、NanoSomiX.、Malvern Panalytical.、Sistemic Sc​​ienceland Limited 和NX PharmaGen 是一些领先的公司全球外泌体研究市场的参与者。

报告范围：

在本报告中，除了产业趋势外，全球外泌体研究市场也分为以下几类：

外泌体研究市场，副产品：

• 试剂盒和试剂
• 仪器
• 其他产品

外泌体研究市场，依适应症分类：

• 癌症
• 神经退化性疾病
• 心血管疾病
• 传染性疾病
• 其他的

外泌体研究市场，按应用：

• 生物标誌物
• 疫苗开发
• 组织再生
• 其他应用

外泌体研究市场，按地区：

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 法国
• 德国
• 英国
• 义大利
• 西班牙
• 亚太地区
• 中国
• 印度
• 日本
• 韩国
• 澳洲
• 南美洲
• 巴西
• 阿根廷
• 哥伦比亚
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿联酋

竞争格局

• 公司概况：全球外泌体研究市场中主要公司的详细分析。

可用的客製化：

• 根据给定的市场资料，TechSci Research 可根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球外泌体研究市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（试剂盒及试剂、仪器、其他产品）
  • 依适应症（癌症、神经退化性疾病、心血管疾病、传染病、其他）
  • 按应用（生物标记、疫苗开发、组织再生、其他应用）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 按产品分类
  • 按指示
  • 按应用
  • 按地区

第 6 章：北美外泌体研究市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（试剂盒及试剂、仪器、其他产品）
  • 依适应症（癌症、神经退化性疾病、心血管疾病、传染病、其他）
  • 按应用（生物标记、疫苗开发、组织再生、其他应用）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲外泌体研究市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（试剂盒及试剂、仪器、其他产品）
  • 依适应症（癌症、神经退化性疾病、心血管疾病、传染病、其他）
  • 按应用（生物标记、疫苗开发、组织再生、其他应用）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：亚太地区外泌体研究市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（试剂盒及试剂、仪器、其他产品）
  • 依适应症（癌症、神经退化性疾病、心血管疾病、传染病、其他）
  • 按应用（生物标记、疫苗开发、组织再生、其他应用）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲外泌体研究市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（试剂盒及试剂、仪器、其他产品）
  • 依适应症（癌症、神经退化性疾病、心血管疾病、传染病、其他）
  • 按应用（生物标记、疫苗开发、组织再生、其他应用）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲外泌体研究市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（试剂盒及试剂、仪器、其他产品）
  • 依适应症（癌症、神经退化性疾病、心血管疾病、传染病、其他）
  • 按应用（生物标记、疫苗开发、组织再生、其他应用）
  • 按国家/地区
• MEA：国家分析
  • 南非外泌体研究
  • 沙乌地阿拉伯外泌体研究
  • 阿联酋外泌体研究

第 11 章：市场动态

• 司机
  • 实验室自动化活动的需求不断增长
  • 生物样本库越来越多地采用实验室资讯学
  • 越来越多引入技术先进的软体服务
• 挑战
  • 缺乏实验室资讯学整合标准
  • 严格的规定

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球外泌体研究市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • Thermo Fisher Scientific.
  • System Biosciences.
  • Bio-Techne.
  • Lonza.
  • QIAGEN.
  • ExoDx.
  • Hitachi Chemical.
  • Aethlon Medical.
  • NanoSomiX.
  • Malvern Panalytical.
  • Sistemic Scotland Limited.
  • NX PharmaGen

第 16 章：策略建议

The exosome research market was valued at USD189.07 million in 2022, and is poised for remarkable growth with a CAGR Of 13.71% by 2028.. This growth can be attributed to a surge in research and development funding, coupled with an escalating prevalence of cancer and a heightened interest in exosome-based procedures. Furthermore, ongoing advancements in exosome technology for drug development and discovery are anticipated to yield lucrative growth during this forecast timeframe. Similarly, the escalating demand for drug therapies and a surge in research and development activities within the pharmaceutical industry remain pivotal factors driving market expansion over the years. Notably, the GLOBOCAN 2020 report underscores that the global cancer population stands at 19.29 million, with expectations of this number to surge over the next two decades worldwide. This mounting occurrence of cancer cases suggests a high potential for exosomes to play a significant role in cancer management, further contributing to the anticipated market growth.

Amplification in Research Funding as a Catalyst for Exosome Market Expansion

The substantial increase in research funding stands as a key driver behind the remarkable growth in the global exosome research market. This escalated funding has empowered researchers to undertake more extensive and comprehensive studies on exosomes, ultimately leading to a more profound understanding of their biology and prospective clinical applications. The augmented research funding has facilitated the development of novel technologies and methodologies for the isolation, analysis, and characterization of exosomes. This, in turn, has resulted in the creation of new products, services, diagnostics, and therapeutic applications within the exosome research market. With heightened funding, researchers can broaden the horizons of exosome research, allowing them to explore novel aspects of exosome biology and investigate their potential roles across a wider spectrum of diseases and conditions. This expanded research scope has significantly bolstered our understanding of the clinical applications of exosomes, thereby driving growth within the exosome research market.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 189.07 Million
Market Size 2028	USD 404.19 Million
CAGR 2023-2028	13.71%
Fastest Growing Segment	Cancer
Largest Market	North America

The increased research funding has transformed exosome research into a more appealing investment area, leading to the establishment of fresh companies and products in the exosome research market. This surge in investment has stimulated innovation and expedited the development of exosome-based therapies and diagnostics. Notably, several companies have expanded their portfolios to encompass exosome-based therapies. For instance, Codiak Biosciences has collaborated with Jazz Pharmaceuticals to pioneer exosome-based therapies for cancer treatment. A pivotal focus within the exosome research market has been the development of improved exosome isolation technologies. Recent advancements in this arena encompass the utilization of microfluidic devices for high-throughput exosome isolation and the formulation of new techniques for isolating exosomes from specific cell types.

Progressive Advancements in Exosome Isolation and Analysis Technologies

Advancements in technologies related to exosome isolation and analysis have exerted a profound impact on the global exosome research market. These breakthroughs have streamlined and enhanced the process of studying exosomes, contributing to a more comprehensive grasp of their biology and potential clinical applications. These technological headways have yielded enhanced accuracy and efficiency, allowing researchers to acquire high-quality exosome samples and conduct analyses with greater speed and precision. This acceleration of research and development activities has consequently driven growth within the exosome research market. Novel technologies have emerged that enable the detection and analysis of even minute quantities of exosomes, elevating the sensitivity of exosome-based assays and ultimately leading to more accurate results. This has unveiled fresh avenues of research and catalyzed the introduction of novel products and services within the exosome research market.

These technological strides have propelled the development of innovative products and services within the exosome research market, encompassing kits for exosome isolation and analysis, exosome-based diagnostics, and exosome-based therapeutics. These offerings have fueled growth within the exosome research market, creating novel prospects for companies operating in this sphere. The augmented accuracy and sensitivity afforded by advancements in exosome isolation and analysis technologies have furnished a more profound understanding of exosome biology and its significance in various diseases and conditions. This enriched comprehension has spurred the evolution of novel diagnostic and therapeutic applications for exosomes, thereby further contributing to the expansion of the exosome research market.

Heightened Awareness of the Clinical Potential of Exosomes Spurs Market Prospects

The burgeoning recognition of exosomes' potential clinical applications has exerted a noteworthy influence on the global exosome research market. As researchers and medical professionals become increasingly acquainted with the unique attributes and functions of exosomes, the interest in their potential as therapeutic and diagnostic tools has grown exponentially. As awareness surrounding the potential clinical applications of exosomes has escalated, investment in the development of exosome-based therapeutics and diagnostics has concurrently surged. This has culminated in the formation of novel companies and products within the exosome research market, thus driving growth and fostering innovation. The potential clinical applications of exosomes span a diverse range of diseases and conditions, including cancer, neurological disorders, and cardiovascular ailments.

The surging awareness of this potential has prompted intensified efforts toward the development of exosome-based therapies, thereby triggering the creation of innovative products and services within the exosome research market. Furthermore, exosomes have demonstrated promise as biomarkers for diagnosing various diseases and conditions. The increasing awareness of this potential has subsequently catalyzed the formulation of new exosome-based diagnostic tests, subsequently propelling the growth of the exosome research market. As exosome-based therapies and diagnostics edge closer to clinical implementation, regulatory bodies have become more deeply involved in the development and approval processes. The growing awareness of exosomes' potential clinical applications has spurred increased regulatory scrutiny, thereby fortifying the safety and efficacy of exosome-based products and services.

Surge in Prevalence of Chronic Diseases Energizes Exosome Research Market

The mounting prevalence of chronic diseases constitutes a significant influence on the global exosome research market. Notably, chronic ailments such as cancer, cardiovascular disease, and neurological disorders present substantial public health challenges, impacting millions globally. Exosomes have emerged as potential diagnostic and therapeutic tools for addressing these and other chronic conditions, consequently fueling growth within the exosome research market.

The upsurge in chronic diseases has prompted intensified research focus, offering a platform to explore the potential roles of exosomes in disease diagnosis, treatment, and monitoring. As researchers delve into the potential of exosomes as biomarkers and therapeutic agents, the market continues to flourish. Exosomes have introduced a new category of therapeutics, capable of delivering drugs and genetic material to specific cells and tissues.

The escalating demand for innovative treatments in response to the increasing prevalence of chronic diseases has propelled the development of exosome-based therapies and products. Remarkably, exosomes are being investigated for their potential as diagnostic tools for a diverse range of chronic ailments. Through the analysis of exosomes present in bodily fluids, researchers can identify biomarkers indicative of disease presence. This has, in turn, spurred the development of fresh exosome-based diagnostic tools, ultimately contributing to the expansion of the exosome research market. As exosomes emerge as a promising solution to the challenges posed by mounting chronic diseases, the exosome research market responds to this demand, attaining growth and relevance.

Market Segmentation

The global exosome research market can be segmented by product, indication, application, and region. Based on the product, the market can be segmented into kits and reagents, instruments, and other products. Based on indication, the market can be differentiated into cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others. Based on application, the market can be grouped into biomarkers, vaccine development, tissue regeneration, and other applications.

Market Players

Thermo Fisher Scientific., System Biosciences., Bio-Techne., Lonza., QIAGEN., ExoDx., Hitachi Chemical., Aethlon Medical., NanoSomiX., Malvern Panalytical., Sistemic Scotland Limited, and NX PharmaGen are some of the leading players operating in the global exosome research market.

Report Scope:

In this report, the global exosome research market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Exosome Research Market, By Product:

• Kits and Reagents
• Instruments
• Other Products

Exosome Research Market, By Indication:

• Cancer
• Neurodegenerative diseases
• Cardiovascular diseases
• Infectious diseases
• Others

Exosome Research Market, By Application:

• Biomarkers
• Vaccine Development
• Tissue Regeneration
• Other Applications

Exosome Research Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Exosome Research Market.

Available Customizations:

• With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Exosome Research Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Kits and Reagents, Instruments, Other Products)
  • 5.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
  • 5.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Products
  • 5.3.2 By Indication
  • 5.3.3 By Application
  • 5.3.4 By Region

6. North America Exosome Research Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Kits and Reagents, Instruments, Other Products)
  • 6.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
  • 6.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Exosome Research Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Exosome Research Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Exosome Research Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Application

7. Europe Exosome Research Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Kits and Reagents, Instruments, Other Products)
  • 7.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
  • 7.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Exosome Research Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Exosome Research Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Exosome Research Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Exosome Research Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Exosome Research Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Application

8. Asia-Pacific Exosome Research Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Kits and Reagents, Instruments, Other Products)
  • 8.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
  • 8.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Exosome Research Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Application
  • 8.3.2. India Exosome Research Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Exosome Research Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Exosome Research Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Exosome Research Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Application

9. South America Exosome Research Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Kits and Reagents, Instruments, Other Products)
  • 9.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
  • 9.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Exosome Research Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Exosome Research Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Exosome Research Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Application

10. Middle East and Africa Exosome Research Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Kits and Reagents, Instruments, Other Products)
  • 10.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
  • 10.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Exosome Research Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Exosome Research Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Exosome Research Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
  • 11.1.1 Growing demand for lab automation activities
  • 11.1.2 Growing adoption of lab informatics by biobanks
  • 11.1.3 Growing introduction of technologically advanced software services
• 11.2. Challenges
  • 11.2.1 Lack of integration standards for laboratory informatics
  • 11.2.2 Stringent Regulations

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Exosome Research Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Thermo Fisher Scientific.
  • 15.6.2 System Biosciences.
  • 15.6.3 Bio-Techne.
  • 15.6.4 Lonza.
  • 15.6.5 QIAGEN.
  • 15.6.6 ExoDx.
  • 15.6.7 Hitachi Chemical.
  • 15.6.8 Aethlon Medical.
  • 15.6.9 NanoSomiX.
  • 15.6.10 Malvern Panalytical.
  • 15.6.11 Sistemic Scotland Limited.
  • 15.6.12 NX PharmaGen

16. Strategic Recommendations